s risk that can be used to predict the age at which a person will develop the disease.A high score on the test, which is based on 31 genetic markers, can translate to being diagnosed many years earlier than those with a low-risk genetic profile, the study found. 
s risk, but whose cumulative influence is substantial.The researchers first identified nearly 2,000 single letter differences in the genetic code (known as SNPs) and, after ranking them for influence, developed a test based on 31 of the markers. 
s risk of getting the disease in an independent patient cohort.In people with the high-risk version of ApoE, those ranked in the top 10% of risk on the new test got Alzheimer?
